Advances in Neonatal Care: Neonatal Abstinence Syndrome and Preterm Infants – A Look at Current Practice

Abstract Background/Significance: Intrauterine opioid drug exposure is associated with an increased risk of preterm birth. Preterm infants may not exhibit the same withdrawal symptoms as term infants diagnosed with neonatal…

Read More from Advances in Neonatal Care: Neonatal Abstinence Syndrome and Preterm Infants – A Look at Current Practice

Hospital Pediatrics: Correlating Scores but Contrasting Outcomes for Eat Sleep Console Versus Modified Finnegan

SOURCE: Ryan et al., Mar 2021, Correlating Scores but Contrasting Outcomes for Eat Sleep Console Versus Modified Finnegan, Hospital Pediatrics, hpeds.2020-003665; DOI: 10.1542/hpeds.2020-003665 OBJECTIVES: The Modified Finnegan Neonatal Abstinence Scoring System (M-FNASS) and the…

Read More from Hospital Pediatrics: Correlating Scores but Contrasting Outcomes for Eat Sleep Console Versus Modified Finnegan

Hospital Pediatrics: Parent Perspectives on the Eat, Sleep, Console Approach for the Care of Opioid-Exposed Infants

SOURCE: Kamelia McRae, Theiju Sebastian, Matthew Grossman, Jaspreet Loyal. Mar 2021. Parent Perspectives on the Eat, Sleep, Console Approach for the Care of Opioid-Exposed Infants, Hospital Pediatrics, hpeds.2020-002139; DOI: 10.1542/hpeds.2020-002139 BACKGROUND: At our institution, the treatment of infants with neonatal abstinence syndrome…

Read More from Hospital Pediatrics: Parent Perspectives on the Eat, Sleep, Console Approach for the Care of Opioid-Exposed Infants

JAMA: Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017

Source: Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017. JAMA. 2021;325(2):146–155. doi:10.1001/jama.2020.24991 Question:  In the US from 2010 to 2017,…

Read More from JAMA: Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017

Neonatal Abstinence Syndrome and Associated Neonatal and Maternal Mortality and Morbidity

SOURCE: Sarka Lisonkova, Lindsay L. Richter, Joseph Ting, Giulia M. Muraca, Qi Wen, AzarMehrabadi, Sheona Mitchell-Foster, Eugenia Oviedo-Joekes, Janet Lyons. Neonatal Abstinence Syndrome and Associated Neonatal and Maternal Mortality and Morbidity, Pediatrics Aug 2019, 144 (2) e20183664; DOI: 10.1542/peds.2018-3664 OBJECTIVES: We examined demographic characteristics and birth outcomes of infants with neonatal abstinence…

Read More from Neonatal Abstinence Syndrome and Associated Neonatal and Maternal Mortality and Morbidity

Systematic mixed‐study review of nonpharmacological management of neonatal abstinence syndrome

Reference: MacVicar, S, Kelly, LE. Systematic mixed‐study review of nonpharmacological management of neonatal abstinence syndrome. Birth. 2019; 00: 1– 11. https://doi.org/10.1111/birt.12427 ABSTRACT BACKGROUND: Neonatal abstinence syndrome is a multisystem disorder resulting from exposure to maternal addictive substance use in…

Read More from Systematic mixed‐study review of nonpharmacological management of neonatal abstinence syndrome

AJOG Article: Opioid Dependence and Pregnancy: Minimizing Stress on the Fetal Brain

Abstract:  Increase in the number of opioid-dependent pregnant women delivering babies at risk for neonatal abstinence syndrome prompted a US Government Accountability Office report documenting deficits in research and provider…

Read More from AJOG Article: Opioid Dependence and Pregnancy: Minimizing Stress on the Fetal Brain

Prescription Monitoring Program (PMP): Mandatory check required beginning Nov. 1

HB 1948, Prescription Monitoring Program (PMP) goes into effect November 1, 2015.  The legislation clarifies language related to the Uniform Controlled Dangerous Substance Act and establishes a Prescription Monitoring Program…

Read More from Prescription Monitoring Program (PMP): Mandatory check required beginning Nov. 1